In the last 12 months, insiders at Viridian Therapeutics, Inc.\DE ($VRDN) filed 64 transactions with the SEC: 5 open-market purchases totaling $50,616,292 and 1 sales totaling $70,796. Net insider sentiment: net buying.
Viridian Therapeutics, Inc.\DE operates in the Pharmaceutical preparations industry (Life sciences sector).
Most Active Insiders
- Fairmount Funds Management LLC (Director) — 6 transactions totaling $40,166,345
- Fairmount Funds Management LLC (Not found) — 5 transactions totaling $9,999,990
- Mahoney Stephen F. (President and CEO) — 9 transactions totaling $946,533
- Beetham Thomas W. (Chief Operating Officer) — 9 transactions totaling $301,075
- Tousignant Jennifer (Chief Legal Officer) — 10 transactions totaling $171,911
View all SEC Filings for Viridian Therapeutics, Inc.\DE (VRDN).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| March 3, 2026 | Tousignant Jennifer | Chief Legal Officer | F | Common Stock | 1675 | $30.19 | 3,494.0000 | 95,442,008 | 32.40% | 0.00% |
| March 3, 2026 | Mahoney Stephen F. | President and CEO | F | Common Stock | 7408 | $30.19 | 33,349.0000 | 95,442,008 | 18.18% | 0.01% |
| March 3, 2026 | Harmon Seth | Chief Financial Officer | F | Common Stock | 2031 | $30.19 | 7,850.0000 | 95,442,008 | 20.55% | 0.00% |
| March 3, 2026 | Beetham Thomas W. | Chief Operating Officer | F | Common Stock | 3048 | $30.19 | 13,361.0000 | 95,442,008 | 18.58% | 0.00% |
| March 2, 2026 | Beetham Thomas W. | Chief Operating Officer | A | Stock Option (Right to Buy) | 176550 | $0.00 | 176,550.0000 | 95,442,008 | 9999.99% | 0.18% |
| March 2, 2026 | Tripuraneni Radhika | Chief Medical Officer | A | Stock Option (Right to Buy) | 95800 | $0.00 | 95,800.0000 | 95,442,008 | 9999.99% | 0.10% |
| March 2, 2026 | Harmon Seth | Chief Financial Officer | A | Stock Option (Right to Buy) | 102850 | $0.00 | 102,850.0000 | 95,442,008 | 9999.99% | 0.11% |
| March 3, 2026 | Harmon Seth | Chief Financial Officer | M | Common Stock | 6267 | $0.00 | 9,881.0000 | 95,442,008 | 173.41% | 0.01% |
| March 3, 2026 | Tousignant Jennifer | Chief Legal Officer | M | Restricted Stock Units | 5169 | $0.00 | 15,510.0000 | 95,442,008 | 25.00% | 0.01% |
| March 2, 2026 | Tousignant Jennifer | Chief Legal Officer | A | Restricted Stock Units | 23850 | $0.00 | 23,850.0000 | 95,442,008 | 9999.99% | 0.02% |
| March 2, 2026 | Tousignant Jennifer | Chief Legal Officer | A | Stock Option (Right to Buy) | 119300 | $0.00 | 119,300.0000 | 95,442,008 | 9999.99% | 0.13% |
| March 3, 2026 | Tousignant Jennifer | Chief Legal Officer | F | Common Stock | 1724 | $29.32 | 3,445.0000 | 95,442,008 | 33.35% | 0.00% |
| March 3, 2026 | Tousignant Jennifer | Chief Legal Officer | M | Common Stock | 5169 | $0.00 | 5,169.0000 | 95,442,008 | 9999.99% | 0.01% |
| March 3, 2026 | Harmon Seth | Chief Financial Officer | F | Common Stock | 2091 | $29.32 | 7,790.0000 | 95,442,008 | 21.16% | 0.00% |
| March 3, 2026 | Mahoney Stephen F. | President and CEO | M | Restricted Stock Units | 18357 | $0.00 | 55,071.0000 | 95,442,008 | 25.00% | 0.02% |
| March 2, 2026 | Mahoney Stephen F. | President and CEO | A | Restricted Stock Units | 111900 | $0.00 | 111,900.0000 | 95,442,008 | 9999.99% | 0.12% |
| March 2, 2026 | Mahoney Stephen F. | President and CEO | A | Stock Option (Right to Buy) | 559600 | $0.00 | 559,600.0000 | 95,442,008 | 9999.99% | 0.59% |
| March 3, 2026 | Mahoney Stephen F. | President and CEO | F | Common Stock | 7627 | $29.32 | 33,130.0000 | 95,442,008 | 18.71% | 0.01% |
| March 3, 2026 | Mahoney Stephen F. | President and CEO | M | Common Stock | 18357 | $0.00 | 40,757.0000 | 95,442,008 | 81.95% | 0.02% |
| March 3, 2026 | Beetham Thomas W. | Chief Operating Officer | M | Restricted Stock Units | 9409 | $0.00 | 28,227.0000 | 95,442,008 | 25.00% | 0.01% |
| March 2, 2026 | Beetham Thomas W. | Chief Operating Officer | A | Restricted Stock Units | 35300 | $0.00 | 35,300.0000 | 95,442,008 | 9999.99% | 0.04% |
| March 2, 2026 | Tripuraneni Radhika | Chief Medical Officer | A | Restricted Stock Units | 19150 | $0.00 | 19,150.0000 | 95,442,008 | 9999.99% | 0.02% |
| March 3, 2026 | Beetham Thomas W. | Chief Operating Officer | F | Common Stock | 3138 | $29.32 | 13,271.0000 | 95,442,008 | 19.12% | 0.00% |
| March 3, 2026 | Beetham Thomas W. | Chief Operating Officer | M | Common Stock | 9409 | $0.00 | 16,409.0000 | 95,442,008 | 134.41% | 0.01% |
| March 3, 2026 | Harmon Seth | Chief Financial Officer | M | Restricted Stock Units | 6267 | $0.00 | 18,801.0000 | 95,442,008 | 25.00% | 0.01% |
| March 2, 2026 | Harmon Seth | Chief Financial Officer | A | Restricted Stock Units | 20550 | $0.00 | 20,550.0000 | 95,442,008 | 9999.99% | 0.02% |
| Dec. 31, 2025 | Tousignant Jennifer | Chief Legal Officer | S | Common Stock | 2272 | $31.16 | 0.0000 | 95,442,008 | 100.00% | 0.00% |
| Oct. 23, 2025 | Fairmount Funds Management LLC | Director | P | Common Stock | 454545 | $22.00 | 3,914,458.0000 | 81,484,950 | 13.14% | 0.56% |
| July 1, 2025 | CAIN CHRISTOPHER W. | Not found | A | Stock Option (Right to Buy) | 21000 | $0.00 | 21,000.0000 | 81,484,950 | 9999.99% | 0.03% |
| July 1, 2025 | Ajer Jeffrey Robert | Not found | A | Stock Option (Right to Buy) | 21000 | $0.00 | 21,000.0000 | 81,484,950 | 9999.99% | 0.03% |
| July 1, 2025 | Kiselak Tomas | Not found | A | Stock Option (Right to Buy) | 21000 | $0.00 | 21,000.0000 | 81,484,950 | 9999.99% | 0.03% |
| July 1, 2025 | Gheuens Sarah | Not found | A | Stock Option (Right to Buy) | 21000 | $0.00 | 21,000.0000 | 81,484,950 | 9999.99% | 0.03% |
| July 1, 2025 | Moses Jennifer K. | Not found | A | Stock Option (Right to Buy) | 21000 | $0.00 | 21,000.0000 | 81,484,950 | 9999.99% | 0.03% |
| July 1, 2025 | Morris Arlene | Not found | A | Stock Option (Right to Buy) | 21000 | $0.00 | 21,000.0000 | 81,484,950 | 9999.99% | 0.03% |
| June 9, 2025 | Fairmount Funds Management LLC | Director | M | Stock Option (Right to Buy) | 1600 | $0.00 | 0.0000 | 81,484,950 | 100.00% | 0.00% |
| June 9, 2025 | Fairmount Funds Management LLC | Director | M | Common Stock | 1600 | $7.80 | 3,447,413.0000 | 81,484,950 | 0.05% | 0.00% |
| June 10, 2025 | Fairmount Funds Management LLC | Director | M | Common Stock | 12500 | $12.31 | 3,459,913.0000 | 81,484,950 | 0.36% | 0.02% |
| June 10, 2025 | Fairmount Funds Management LLC | Director | M | Stock Option (Right to Buy) | 12500 | $0.00 | 0.0000 | 81,484,950 | 100.00% | 0.02% |
| April 7, 2025 | Ajer Jeffrey Robert | Not found | A | Stock Option (Right to Buy) | 42000 | $0.00 | 42,000.0000 | 81,484,950 | 9999.99% | 0.05% |
| March 10, 2025 | Tripuraneni Radhika | Chief Medical Officer | A | Stock Option (Right to Buy) | 310700 | $0.00 | 310,700.0000 | 81,484,950 | 9999.99% | 0.38% |
| March 10, 2025 | CAIN CHRISTOPHER W. | Not found | A | Stock Option (Right to Buy) | 42000 | $0.00 | 42,000.0000 | 81,484,950 | 9999.99% | 0.05% |
| March 3, 2025 | Mahoney Stephen F. | President and CEO | A | Stock Option (Right to Buy) | 440565 | $0.00 | 440,565.0000 | 81,484,950 | 9999.99% | 0.54% |
| March 3, 2025 | Mahoney Stephen F. | President and CEO | A | Restricted Stock Units | 73428 | $0.00 | 73,428.0000 | 81,484,950 | 9999.99% | 0.09% |
| March 3, 2025 | Beetham Thomas W. | Chief Operating Officer | A | Stock Option (Right to Buy) | 225814 | $0.00 | 225,814.0000 | 81,484,950 | 9999.99% | 0.28% |
| March 3, 2025 | Beetham Thomas W. | Chief Operating Officer | A | Restricted Stock Units | 37636 | $0.00 | 37,636.0000 | 81,484,950 | 9999.99% | 0.05% |
| March 3, 2025 | Harmon Seth | Chief Financial Officer | A | Restricted Stock Units | 25068 | $0.00 | 25,068.0000 | 81,484,950 | 9999.99% | 0.03% |
| March 3, 2025 | Harmon Seth | Chief Financial Officer | A | Stock Option (Right to Buy) | 150407 | $0.00 | 150,407.0000 | 81,484,950 | 9999.99% | 0.18% |
| March 3, 2025 | Tousignant Jennifer | Chief Legal Officer | A | Stock Option (Right to Buy) | 124072 | $0.00 | 124,072.0000 | 81,484,950 | 9999.99% | 0.15% |
| March 3, 2025 | Tousignant Jennifer | Chief Legal Officer | A | Restricted Stock Units | 20679 | $0.00 | 20,679.0000 | 81,484,950 | 9999.99% | 0.03% |
| Sept. 27, 2024 | Mahoney Stephen F. | President and CEO | P | Common Stock | 21400 | $23.33 | 21,400.0000 | 0 | 9999.99% | 0.00% |
| Sept. 27, 2024 | Beetham Thomas W. | Chief Operating Officer | P | Common Stock | 5000 | $23.41 | 6,000.0000 | 0 | 500.00% | 0.00% |
| Sept. 13, 2024 | Fairmount Funds Management LLC | Director | P | Common Stock | 1600000 | $18.75 | 3,445,813.0000 | 0 | 86.68% | 0.00% |
| June 26, 2024 | Gheuens Sarah | Not found | A | Stock Option (Right to Buy) | 21000 | $0.00 | 21,000.0000 | 0 | 9999.99% | 0.00% |
| June 26, 2024 | Morris Arlene | Not found | A | Stock Option (Right to Buy) | 21000 | $0.00 | 21,000.0000 | 0 | 9999.99% | 0.00% |
| June 26, 2024 | Moses Jennifer K. | Not found | A | Stock Option (Right to Buy) | 21000 | $0.00 | 21,000.0000 | 0 | 9999.99% | 0.00% |
| June 26, 2024 | Harwin Peter Evan | Not found | A | Stock Option (Right to Buy) | 21000 | $0.00 | 21,000.0000 | 0 | 9999.99% | 0.00% |
| June 26, 2024 | Kiselak Tomas | Not found | A | Stock Option (Right to Buy) | 21000 | $0.00 | 21,000.0000 | 0 | 9999.99% | 0.00% |
| March 28, 2024 | Fairmount Funds Management LLC | Not found | J | Series A Non-Voting Convertible Preferred Stock | 21999 | $0.00 | 133,191.0000 | 0 | 14.18% | 0.00% |
| March 28, 2024 | Fairmount Funds Management LLC | Not found | J | Common Stock | 5859 | $0.00 | 1,845,813.0000 | 0 | 0.32% | 0.00% |
| March 28, 2024 | Fairmount Funds Management LLC | Not found | J | Common Stock | 5859 | $0.00 | 1,845,813.0000 | 0 | 0.32% | 0.00% |
| March 28, 2024 | Fairmount Funds Management LLC | Not found | J | Series A Non-Voting Convertible Preferred Stock | 21999 | $0.00 | 133,191.0000 | 0 | 19.78% | 0.00% |
| Feb. 12, 2024 | Tousignant Jennifer | Chief Legal Officer | A | Stock Option (Right to Buy) | 290000 | $0.00 | 290,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 5, 2024 | Ciulla Thomas | Chief Medical Officer | A | Stock Option (Right to Buy) | 50000 | $0.00 | 50,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 22, 2024 | Fairmount Funds Management LLC | Not found | P | Common Stock | 476190 | $21.00 | 1,845,813.0000 | 0 | 34.77% | 0.00% |